Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin L Kagan

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Molecular and Cellular Endocrinology|June 28, 2008
Modulation of transcription parameters in glucocorticoid receptor-mediated repressionYunguang Sun, Yong-Guang Tao, Benjamin L Kagan, et al.
Breast Cancer Research and Treatment|May 7, 2009
The role and regulation of the nuclear receptor co-activator AIB1 in breast cancerTyler Lahusen, Ralf T Henke, Benjamin L Kagan, et al.
Molecular Endocrinology (Baltimore, Md.)|November 13, 2004
Glucocorticoid receptor ligand binding domain is sufficient for the modulation of glucocorticoid induction properties by homologous receptors, coactivator transcription intermediary factor 2, and Ubc9Sehyung Cho, Benjamin L Kagan, John A Blackford, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2010
A theoretical framework for gene induction and experimental comparisonsKaren M Ong, John A Blackford, Benjamin L Kagan, et al.
Cancer Research|April 3, 2003
Complex regulation of the fibroblast growth factor-binding protein in MDA- MB-468 breast cancer cells by CCAAT/enhancer-binding protein betaBenjamin L Kagan, Ralf T Henke, Rafael Cabal-Manzano, et al.
Molecular and Cellular Biology|September 4, 2008
Tyrosine phosphorylation of the nuclear receptor coactivator AIB1/SRC-3 is enhanced by Abl kinase and is required for its activity in cancer cellsAnnabell S Oh, John T Lahusen, Christopher D Chien, et al.
Plos One|July 9, 2011
Proteomic analysis of pathways involved in estrogen-induced growth and apoptosis of breast cancer cellsZhang-Zhi Hu, Benjamin L Kagan, Eric A Ariazi, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Molecular and Cellular Endocrinology|June 28, 2008
Modulation of transcription parameters in glucocorticoid receptor-mediated repressionYunguang Sun, Yong-Guang Tao, Benjamin L Kagan, et al.
Breast Cancer Research and Treatment|May 7, 2009
The role and regulation of the nuclear receptor co-activator AIB1 in breast cancerTyler Lahusen, Ralf T Henke, Benjamin L Kagan, et al.
Molecular Endocrinology (Baltimore, Md.)|November 13, 2004
Glucocorticoid receptor ligand binding domain is sufficient for the modulation of glucocorticoid induction properties by homologous receptors, coactivator transcription intermediary factor 2, and Ubc9Sehyung Cho, Benjamin L Kagan, John A Blackford, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2010
A theoretical framework for gene induction and experimental comparisonsKaren M Ong, John A Blackford, Benjamin L Kagan, et al.
Cancer Research|April 3, 2003
Complex regulation of the fibroblast growth factor-binding protein in MDA- MB-468 breast cancer cells by CCAAT/enhancer-binding protein betaBenjamin L Kagan, Ralf T Henke, Rafael Cabal-Manzano, et al.
Molecular and Cellular Biology|September 4, 2008
Tyrosine phosphorylation of the nuclear receptor coactivator AIB1/SRC-3 is enhanced by Abl kinase and is required for its activity in cancer cellsAnnabell S Oh, John T Lahusen, Christopher D Chien, et al.
Plos One|July 9, 2011
Proteomic analysis of pathways involved in estrogen-induced growth and apoptosis of breast cancer cellsZhang-Zhi Hu, Benjamin L Kagan, Eric A Ariazi, et al.
Pageof 1